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West Nile (WN) virus, the causative agent of WN fever
and encephalitis, has a wide distribution in Africa, West Asia,
and the Middle East, and outbreaks have been reported from
Europe, South Africa, and Israel. Wild and domestic birds are
the principal amplifying hosts of WN virus, and ornithophilic
mosquitoes of the Culex species are the major vectors (1).
In late August 1999, the first reported outbreak of WN
encephalitis in the Western Hemisphere occurred in New
York City and surrounding areas. A high degree of genomic
sequence similarity between virus isolates indicated that a
single WN viral strain was introduced and circulated during
the outbreak (2). A high (>99.8%) genomic similarity was also
found between the U.S. viral isolates and a WN virus strain
isolated from the brain of a dead goose in Israel in 1998 (2).
How WN virus was introduced into the United States is
not known. The high degree of similarity between the 1999
U.S. isolates and the 1998 Israeli isolate, however, raised the
hypothesis that the U.S. epidemic originated from the
introduction of a WN virus strain that had been circulating in
Israel and surrounding countries (2). We provide more
evidence to support this hypothesis.
Case Reports
Case 1
On August 24, 1999, a 75-year-old man was admitted to a
Tel Aviv emergency room, with confusion, disorientation, and
somnolence of 3 days’ duration. Body temperature was
37.5°C. He was conscious but disoriented, with global
aphasia. Routine laboratory test results, including cere-
brospinal fluid (CSF) examination, were normal. A chest
radiograph as well as electroencephalography (EEG) were
normal. Computerized tomography (CT) of the brain was
noncontributory. Over the next 6 days, the patient’s
temperature rose to 39.0°C. He became stuporous, and
myoclonic jerks, as well as snout and palmo-mental
pathologic reflexes, were observed. Repeat lumbar puncture
revealed clear CSF with opening pressure of 160 mm H2O,
protein 1.36 g/L, glucose 0.6 g/L, leukocytes 120/mm3 with
60% polymorphonuclear leukocytes (PMN), and 40%
lymphocytes. EEG showed nonspecific, nonfocal, triphasic
slow waves. Empirical treatment with acyclovir, ceftriaxone,
and erythromycin was begun. During week 2 of hospitaliza-
tion, the patient became less responsive, with limb spasticity,
bilateral ptosis, facial nerve paralysis, and bilateral Babinski
response. T2-weighted magnetic resonance imaging showed
bilateral nonspecific hyperintense foci in the white matter,
with lacunar changes in the striatum. Mechanical ventilation
was started. Biopsy of the cerebral cortex and white matter
showed reactive gliosis, isolated foci of neuronophagia, and a
scanty perivascular lymphocytic infiltrate. Gradual, slow
neurologic improvement was noticed starting on week 8 of
hospitalization. On week 12, the patient was fully alert, with
a tracheostomy but no ventilatory support. He died several
months later in a rehabilitation center from bilateral
pneumonia.
Case 2
The 75-year-old wife of patient 1 was admitted to the
same hospital on August 28, 1999 (4 days after her husband’s
admission), with fever of 39.0°C, chills, dizziness, and
headache. A chest radiograph was consistent with right
basilar pneumonia. Routine laboratory test results were
notable only for a serum sodium level of 132 mEq/L. Empirical
treatment with intravenous cefuroxime and oral roxithromy-
cin was started. On day 4 of hospitalization, the patient
became stuporous with severe respiratory acidosis; mechani-
cal ventilation was begun. Brain CT results were normal.
Lumbar puncture showed an opening pressure of 200 mm
H2O, protein 2.74 g/L, glucose 1.39 g/L, leukocyte count
25/mm3, 80% PMN, and 20% lymphocytes. Acyclovir was
added, and various antibiotic regimens were given. The
patient remained febrile and stuporous and died on day 33 of
hospitalization. Postmortem examination revealed mild,
diffuse encephalitis involving the brain stem, and isolated
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microinfarction of the basal ganglia. Bilateral pulmonary
atelectasis with chronic bronchitis was also noted.
These two patients, a retired engineer and a housewife,
shared an apartment in a suburb of Tel Aviv. They did not
have any pets and had not left the Tel Aviv area in the
preceding 5 years. They had no contact with other patients
with similar clinical manifestations, nor had they entertained
visitors from other countries, except their son, who had visited
Germany 1 month before onset of his father’s illness. An
inspection by the municipal health authorities did not find
mosquito infestation in the local area.
Paired CSF and serum specimens from both patients
tested negative for bacteria, mycobacteria, fungi, and a large
number of viruses. Results of screening tests of urine and
blood for toxic substances, including botulism toxin, were also
negative.
Methods
Immunoglobulin (Ig) M-capture enzyme-linked immun-
osorbent assay (ELISA) and IgG ELISA were performed as
described by Martin et al. (3) and Johnson et al. (4),
respectively. Antigens were prepared as sucrose-acetone
extracts of infected suckling mouse brains or infected C6/36
cell cultures. Positive-to-negative absorbance ratios (P/Ns)
were determined by dividing the average optical density (OD)
of the unknown sera by the average OD measured for the
negative sera, with values >3.0 considered positive. All
specimens and controls were tested in triplicate. The serum-
dilution plaque reduction neutralization test (PRNT) was
performed in Vero cells, as described (5). The following
viruses were used: WN virus strain Eg101, dengue-2 (DEN-2)
strain New Guinea C, and Japanese encephalitis (JE) virus
strain Nakayama. Endpoints were determined at a 90%
plaque-reduction level. A titer of 1:20 was considered a
positive cutoff for PRNT results.
Fragments of brain cerebral tissue from the two patients
were subjected to RNA extraction and reverse transcription-
polymerase chain reaction (RT-PCR) using two different
primer/probe pairs in the TaqMan assay, as described (6). For
nucleic acid sequencing, the viral RNA was amplified and
copied into five unique DNA fragments using the following
WN/Kunjin virus primer pairs: 212/619c, 848/1442c, 1248/
1830c, 9661/10,489c, and 10,571/10,815c (numbers denote
positions of the primers at the Kunjin virus sequence;
GenBank Accession Number D00246). DyeDeoxy Terminator
cycle sequencing was performed as described (2).
Results
Table 1 summarizes the serologic test results of both
patients. In case 1, IgM antibody to WN virus was detected in
serum by day 9 after onset of symptoms (P/N = 13.8). IgM was
also detected in CSF on day 14 (P/N = 21.6) but not on day 3.
In case 2, IgM antibody to WN virus was detected in both CSF
and serum. PRNT results were positive in both cases. Patient
1 had a sixfold increase in antibody titer, 1:10 on day 9 and
1:640 on day 35 after onset of symptoms. In case 1, the positive
IgM ELISA result with JE viral antigen is due to known cross-
reactive antibody response to closely related flaviviruses.
The TaqMan RT-PCR assay performed on RNA extracted
from the patient 1 brain biopsy specimen, obtained 33 days
after onset of clinical symptoms, showed WN viral RNA when
two different primer/probe sets designed from unique regions
of the WN viral genome (Ct-envelope primers = 29.6, Ct-3'
non-coding primers = 29.2; where Ct = threshold cycle and Ct
values <37.5 are positive) were used. The quantity of viral
RNA detected was 8.3 and 9.7 PFU equivalents, based on the
standard curve generated in the TaqMan assay. Nucleic acid
sequencing of the five RT-PCR-generated DNA fragments
yielded 1,861 bp of data, approximately 17% of the total
genome. Sequence comparisons demonstrated that the virus
strain that infected patient 1 is most closely related to the
WN-Israel 1998 strain isolated at the Pasteur Institute from
a dead goose in Israel in 1998 (99.9% sequence homology;
GenBank Accession Number AF205882) and to the WN-NY99
strain isolated from a dead flamingo in the Bronx Zoo, New
York, in 1999 (99.8% sequence homology; GenBank Accession
Number AF196835). Alignment of the sequence data revealed
three positions of nucleotide differences between these three
strains (positions 1,118, 1,285, and 10,851; Table 2). These
nucleotide differences confirm that the WN virus strain
Table 1. Antibodies to West Nile virus and clinically related flaviviruses
in two encephalitis cases, Tel Aviv, 1999
CSF  CSF
Case 1      Serum #1       Serum #2  #1   #2
Daysa   9   35    3  14
Antigen IgMb IgGb PRNTc IgM  IgG PRNT  IgM  IgM
WN 13.8 1  10 13.7 3.6 640 0.9 21.6
Den 1-4   2.3 1.2 <10   2.6 1.7 <10 1   1.7
CHIK   0.9 1.2   0.9 1.2 1.2   1
SIN   1 1.2   1.1 1.2 1.1   1.1
POW/TBE   1 1.1   1.2 1.8 0.9   0.8
JE   2.8 0.8 <5   6.2 0.8   20 1.5   1.7
Case 2
Daysa 14  NA    7  NA
Antigen IgM IgG PRNT IgM
WN 13.5 3.1 80 25.3
Den 1-4   1.7 1.3   1.4
CHIK   1 1.4   0.9
SIN   1.3 1.4   0.9
POW/TBE   1.1 1.4   1
JE   2.5 0.8   5   2.1
CSF = cerebrospinal fluid; CHIK, Chikungunya virus; Den 1-4 =  dengue virus
(types 1-4); JE = Japanese encephalitis virus; NA =  not available; POW/TBE =
Powassan virus/tick-borne encephalitis virus; PRNT = plaque-reduction
neutralization test; SIN = Sindbis virus; WN = West Nile virus.
aDays = days after onset.
bImmunoglobulin M (IgM) and IgG antibody levels were determined by enzyme
immunoassay. Results are expressed as positive-negative absorbance ratios (P/
Ns), determined by dividing the average optical density of the test sera by the
average optical density measured for the negative control sera, with values
>3.0 considered to be positive.
cResults of the PRNT are expressed as reciprocal antibody titers, with values
>20 considered to be positive.
Table 2. Nucleotide differences detected between West Nile (WN) virus
genomic sequence data from patient 1, WN-Israel 1998, and WN-NY99
WN  Sequences
virus  amplified WN-
nucleotide  from brain Israel  WN-
position of patient 1 1998a NY99b
1,118 C C T
1,285 C C T
10,851 G A A
aWN-Israel 1998 was isolated at the Pasteur Institute from a dead goose found
in Israel in 1998.
bWN-NY99 was isolated from a dead flamingo in the Bronx Zoo, New York,
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detected in the brain sample from patient 1 is not a laboratory
contaminant. RT-PCR performed on an autopsy cerebral
cortex brain specimen from patient 2 was negative.
Discussion
Epidemics of WN viral disease occurred in Israel in the
1950s and in 1980 (7,8). During 1997 and 1998, WN virus was
reported, for the first time, as the cause of illness and death
among domestic geese in Israel. Approximately 3,000 geese
with a high seroprevalence of anti-WN virus antibodies were
killed to contain the epizootic (9,10). However, no human
cases of WN fever were reported in Israel in 1997 to 1998 and,
to the best of our knowledge, the two cases described in this
report are the first and only human cases of WN fever reported
in Israel in the 1990s. It seems likely that other such cases
occurred in 1997 to 1999 but were unrecognized, not reported,
or both.
Case 1 meets the criteria for the Centers for Disease
Control and Prevention surveillance case definition of a
confirmed WN encephalitis case (11). Although paired serum
specimens were unavailable for case 2, the presence of WN
IgM in the CSF (P/N = 25.3) and serum (P/N = 13.5) specimens
obtained on day 7 and day 14, respectively, and the presence
of WN virus-specific neutralizing antibodies in serum confirm
this as a WN encephalitis case as well. The negative RT-PCR
result on the autopsy brain specimen in case 2 is probably due
to the fact that the specimen submitted for PCR was from the
cerebral cortex which, on histopathologic examination, was
not involved in the encephalitic process.
Several lines of evidence connect these 1999 Israeli cases
with the 1999 New York WN virus outbreak. First, the Israeli
and the initial American cases occurred in August 1999.
Second, when genomic sequences of WN virus isolates from
the New York outbreak were compared with various non-U.S.
WN virus strains, the highest similarity (>99.8%) was found
with a WN virus strain from a goose that died in the 1998
Israeli epizootic (2). Similar findings were reported in another
study (12). The WN virus sequences obtained by RT-PCR from
a brain biopsy of the Israeli male patient shared a >99%
homology with the 1999 New York and 1998 Israeli avian WN
virus strains, respectively. Finally, in nature avian death
caused by WN virus infection is a new phenomenon observed
only in Israel and the United States (9,13).
During the summer of 2000, an epidemic of WN fever was
observed in Israel, resulting in 417 serologically confirmed
cases and 28 deaths (10). Several WN encephalitis cases were
reported from the neighborhood of the two patients in our
report. Although the genomic sequences of the isolates from
2000 are not yet available, the WN virus strain circulating in
Israel since at least 1998 is likely the causative agent of the
2000 Israel epidemic as well as the 1999 New York outbreak.
How this strain was transported from Israel to the United
States (by infected humans, birds, mosquitoes, or other
animals) remains a matter of conjecture.
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